Rather than try to kill dividing tumor cells, as most cancer drugs do, the contact inhibition program was designed to find compounds that halt them in their tracks another way. Cell-cell and cell ...

There’s an increasing focus on using drugs to modify the tumour microenvironment, breaking down this blockade that supports tumour development and preventing penetration of cancer-killing immune ...

A new study from Cedars-Sinai Cancer reveals a potential way to overcome ... that share many characteristics with actual tumors. "We showed that inhibition of a gene called NPEPPS increased ...

A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today announced significant progress in its ...